Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 March 2021

What do Africa, human rights, and transformation have to do with one another? Are human rights instruments for transformation in Africa, neo-colonial impositions, or the last refuge of the privileged? Is transformation a desirable goal for Africa, or a red herring to make us forget about the real work of decolonisation?

The Department of Public Law and the Free State Centre for Human Rights in the Faculty of Law at the University of the Free State invite you to a webinar on Africa / Human rights / Transformation’ – a conversation with Johan Froneman, Dhaya Pillay, and Toyin Falola as part of Human Rights Week 2021.

The panel will discuss these and related issues from their perspectives as judges, academics, and politically aware Africans of different hues and origins. Prof Karin van Marle will be the moderator.

Date: 16 March 2021

Time: 15:00-16:30

Virtual event, details, and link to be provided upon RSVP to FSCHR@ufs.ac.za

Information on the speakers

Prof Toyin Falola is the Jacob and Frances Sanger Mossiker Chair in the Humanities at the University of Texas, Austin, and an extraordinary professor in the Free State Centre for Human Rights, University of the Free State.

Judge Dhaya Pillay is a judge of the High Court of South Africa (KwaZulu-Natal), Commissioner on the Independent Electoral Commission, and extraordinary professor in the Free State Centre for Human Rights, University of the Free State.

Judge Johan Froneman is a retired judge of the Constitutional Court of South Africa, and extraordinary professor in the Department of Public Law at the University of the Free State.

Prof Karin van Marle is professor of Jurisprudence at the University of the Free State.

News Archive

Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Description: Prof Riaz Seedat Tags: Prof Riaz Seedat

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS

Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.

He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.

Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.

The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.

Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.

“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.

“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept